Promimic
29.4 SEK +1.38%1 investor is following this company
Promimic specializes in biotechnology. The company conducts research and development in surface modifications. Examples of specialist areas include surface modifications for osseointegration for orthopedic and dental implants. The main operations are in Europe and America, where research and development are conducted in-house but also through partners.
Revenue
37.07M
EBIT %
-24.6 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
PRO
Daily low / high price
27.1 / 29.4
SEK
Market cap
548.53M SEK
Turnover
4.51K SEK
Volume
165
Financial calendar
General meeting
2024-05-22
Interim report
2024-05-22
Interim report
2024-08-22
Interim report
2024-11-21
Annual report
2025-02-25
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
K-Svets Venture AB | 38.7 % | 38.7 % |
KDev Investments AB | 12.5 % | 12.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Grundarna säljer del av sitt aktieinnehav i Promimic AB (publ)
Promimic AB: Promimic växer med 129 procent under 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools